Pharmaceutical Companies Sue Biden Administration Over Alleged APA Violations in Medicare Drug Pricing Program
Pharmaceutical companies, including AstraZeneca and Boehringer Ingelheim, are suing the Biden Administration over its plan to [...]
Medicare Drug Price Negotiations Predicted to Yield $1.8 Billion Savings by 2026
A new report asserts that the Inflation Reduction Act will enforce a minimum discount that surpasses the 2020 rebates for [...]
Unmasking Healthcare Costs: Beyond Transparency
What You Need to Know: Policymakers have shifted focus towards price transparency in healthcare to combat escalating costs; however, merely [...]
Will the Medicare Price Negotiation Revamp Sufficiently Appease Pharma Companies?
The Centers for Medicare & Medicaid Services (CMS) amendments to its drug pricing negotiation program will unlikely deter past, current, [...]
US Supreme Court to Consider Medicare Drug Pricing Challenge
The Supreme Court will consider a challenge brought forth by safety net hospitals. A Trump-era ruling leading to reduced drug [...]
Trump Seeks to Send Seniors $8 Billion in Drug Discount Cards on Eve of Election
Yesterday The Washington Post provided an update on President Trump’s plan to mail $200 drug-discount cards to approximately 40 million Medicare [...]
NPC: CMS Proposed Rule Hinders Value-Based Arrangements
In a letter to the Centers for Medicare and Medicaid Services, the National Pharmaceutical Council (NPC) outlines some key issues [...]
Shulkin: COVID-19 Laying Foundation for ‘Tsunami of Challenges’ for Health System
David Shulkin, former secretary of the Department of Veterans Affairs, says the COVID-19 crisis is ultimately generating a "tsunami of [...]
Datta: CMS Proposal a ‘Grab-bag of Issues’
Sidley Austin LLP's Meena Datta told HealthLeaders that the Centers for Medicare and Medicaid Services' (CMS) latest proposal is a [...]
Zemcik, Fry Spotlight CMS Best Price Proposal
Commercial Solutions' Rick Fry and TrialCard's Jason Zemcik spotlight the Centers for Medicare and Medicaid Services' best price proposal in [...]
Bach Outlines ‘Gaping’ Loophole in Medicaid Proposal
A Centers for Medicare and Medicaid Services proposal includes a "gaping" loophole through which drugmakers could avoid selling drugs to [...]
Opinion: Discuss Price for COVID-19 Vaccine Now, Not Later
The U.S. should begin pricing discussions for a COVID-19 vaccine before we get "stuck paying dearly for shots that the [...]
Article: Researchers Point to Germany’s Model for Purchasing Cancer Drugs
Researchers say U.S. policymakers should look to Germany's drug purchasing model to try and better align cancer drug prices with [...]
Report: European Drug Regulatory Network Faces Uncertain, Complex Future
A new strategy produced by European regulators considers future challenges for the European drug regulatory network, The Pink Sheet reports. [...]
Study Finds Inconsistent Reimbursement Assessments Across EU Markets
While some modifications in the HTA process for orphan drugs have had some positive impacts, manufacturers still face key hurdles [...]
Report: FDA Mandates 50% Efficacy for COVID-19 Vaccines
Vaccine candidates must be at least 50 percent more effective than a placebo to be considered for Food and Drug [...]
Proposed Medicaid Changes Aim to Foster Innovative Contracts
The Centers for Medicare and Medicaid Services (CMS) is hoping to encourage greater use of innovative contracting models in a [...]
Legislation Aims to Prevent Pharma From Price-gouging During Pandemic
Two new bipartisan bills introduced by House Democrats aim to prevent the pharmaceutical industry from engaging in price-gouging on COVID-19 [...]
Report Reveals Racial Disparities in COVID-19 Outcomes
New data released by the government on Monday suggests black Americans under Medicare were roughly four times more likely as [...]
Hahn: Some COVID-19 Changes to Remain
Food and Drug Administration (FDA) Chief Stephen Hahn recently said some changes made to address COVID-19 will remain in place, [...]
Blog Post Touts VA, ICER Partnership as ‘Highly Beneficial’
The partnership between the Department of Veterans Affairs (VA) and the Institute for Clinical and Economic Review (ICER) has provided [...]
Report: EMA Considers Big Data Network ‘Priority’
The European Medicines Agency (EMA) says the development of a big data network is a "priority" project, according to a [...]
Report: Hospitals Paid CEO Millions While Laying Off Thousands
Despite having received billions in emergency funds through the CARES Act, some of the nation's top hospital systems have been [...]
OptumRx: Payers Should Monitor Three Key Drugs
OptumRx in its latest drug pipeline update recommends payers to keep an eye on risdiplam, viltolarsen and trodelvy, FierceHealthcare reports. [...]
Trump Administration Picks Five Companies in Operation Warp Speed
The Trump administration has selected five drugmakers as being most likely to develop a coronavirus vaccine, The New York Times [...]
